好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, February 27, 2017

Good News for Kids with Epilepsy

MINNEAPOLIS -

There鈥檚 good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children. But an analysis of all the research published on adults and children shows that the positive results seen in adults appear to be similar in children. The preliminary meta-analysis was released today and will be presented at the 好色先生鈥檚 69th Annual Meeting in Boston, April 22 to 28, 2017. 鈥淭he results of this analysis may bring new hope for children and teens with epilepsy and their families,鈥 said Douglas R. Nordli, Jr., MD, of Children鈥檚 Hospital Los Angeles in Los Angeles, Calif., and a member of the 好色先生. The analysis evaluated only studies of people with primary generalized tonic-clonic seizures. Tonic-clonic seizures are what people typically think of as a seizure. They involve loss of consciousness, stiffening of muscles and jerking movements. Primary generalized seizures means the whole brain is affected. For the analysis, researchers analyzed all randomized, placebo-controlled trials of drugs for this type of seizure in adults and children published from 1970 to 2015. The studies were looking at drugs that are taken in combination with another epilepsy medication. Seven studies were found that met the criteria, one study on children, two on both adults and children and four on adults. The researchers looked at the average percentage reduction in seizure frequency and the percentage of people whose seizures were reduced by 50 percent or more. For the studies in adults, the results were extrapolated to estimate the effect on children. The analysis showed that the effectiveness of the medicines was similar in adults and children and the effectiveness of the drugs did not depend on the age of the patient. 鈥淭he results consistently showed that the epilepsy drug was beneficial compared to the placebo, and the results were comparable between adult and pediatric groups,鈥 Nordli said. 鈥淪ince only about 50 percent of kids become seizure free after trying their first medication, it鈥檚 vitally important to have additional options for kids so they can get back to being kids.鈥 The study was supported by Eisai, Inc. Learn more about epilepsy at .

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .

Related Media